Global Next-Generation Biomanufacturing Market – Analysis and Forecast, 2019-2029

Focus on Workflow, Product Type, Medical Applications, End Users, 5 Regional Data, 19 Countries’ Data, and Competitive Landscape

Published Year: 2020
SKU: BHL0806SA

5000

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Product Definition

2 Scope of the Work

         2.1    Overview: Report Scope
         2.2    Segmentation of the Global Next-Generation Biomanufacturing Market
         2.3    Assumptions and Limitations
         2.4    Key Questions Answered in the Report
         2.5    Base Year and Forecast Period

3 Research Methodology

      3.1    Overview: Report Methodology

4 Global Next-Generation Biomanufacturing Market Overview

         4.1    Ever-Evolving Healthcare Scenario
         4.2    Biomanufacturing: An Introduction
         4.3    Upstream and Downstream Processing
         4.4    Biopharmaceutical Market Growth Boosting Demand for Biomanufacturing
         4.5    Key Technology Trends
         4.6    The Future of Biomanufacturing: Next-Generation Biomanufacturing
         4.7    Global Next-Generation Biomanufacturing Market Size
         4.8    Market Dynamics
                  4.8.1    Impact Analysis of Market Dynamics
         4.9    Assumptions and Limitations

5 Industry Insights

         5.1    Overview
         5.2    Regulatory Scenario
         5.3    Patent Landscape

6 Competitive Landscape

         6.1    Overview
         6.2    Key Developments and Strategies
                  6.2.1    Partnerships and Alliances
                  6.2.2    Business Expansions
                  6.2.3    New Offerings
                  6.2.4    M & A Activities
                  6.2.5    Others
         6.3    Market Share Analysis

7 Global Next-Generation Biomanufacturing Market (by Workflow and Product)

         7.1    Overview
         7.2    Upstream Biomanufacturing
                  7.2.1    Continuous Upstream Biomanufacturing Products
                              7.2.1.1    Bioreactors/Fermenters
                              7.2.1.2    Bags and Containers
                              7.2.1.3     Cell Culture Products
                              7.2.1.4    Filtration Systems
                              7.2.1.5    Mixing Systems
                              7.2.1.6    Sterilizers
                              7.2.1.7    Biosafety Cabinets
                              7.2.1.8    Incubators
                              7.2.1.9    Other Instruments and Accessories
                  7.2.2    Single-Use Upstream Biomanufacturing Products
                              7.2.2.1    Single-Use Bioreactors/Fermenters
                                             7.2.2.2    Single-Use Bags and Containers
                                             7.2.2.3    Single-Use Tubing and Connectors
                                             7.2.2.4    Single-Use Mixing Systems
                                             7.2.2.5    Single-Use Sensors and Probes
         7.3    Downstream Processing
                  7.3.1    Downstream Biomanufacturing Products
                              7.3.1.1    Chromatography Systems
                              7.3.1.2    Filtration Systems
                              7.3.1.3    Membrane Adsorbers
                              7.3.1.4    Instruments and Accessories
                              7.3.1.5    Single-Use Equipment and Accessories

8 Global Next-Generation Biomanufacturing Market (by Medical Application)

         8.1    Overview
         8.2    Monoclonal Antibodies
         8.3    Vaccines
         8.4    Recombinant Proteins
         8.5    Hormones
         8.6    Others

9 Global Next-Generation Biomanufacturing Market (by End User)

         9.1    Overview
         9.2    Biopharmaceutical Companies
         9.3    CMOs/CDMOs
         9.4    Research Institutions

10 Global Next-Generation Biomanufacturing Market (by Region)

           10.1    Overview
           10.2    North America
                      10.2.1    Overview
                      10.2.2    U.S.
                      10.2.3    Canada
           10.3    Europe
                      10.3.1    Overview
                      10.3.2    Germany
                      10.3.3    France
                      10.3.4    U.K.
                      10.3.5    Italy
                      10.3.6    Spain
                      10.3.7    Ireland
                      10.3.8    Switzerland
                      10.3.9    Russia
                      10.3.10   Rest-of-Europe
           10.4    Asia-Pacific
                      10.4.1    Overview
                      10.4.2    China
                      10.4.3    Japan
                      10.4.4    India
                      10.4.5    South Korea
                      10.4.6    Australia
                      10.4.7    Singapore
                      10.4.8    Rest-of-Asia-Pacific
            10.5    Latin America
            10.6    Middle East & Africa

11 Company Profiles

           11.1    Overview
           11.2    Applikon Biotechnology BV
                      11.2.1    Company Overview
                      11.2.2    Role of Applikon Biotechnology BV in the Global Next-Generation Biomanufacturing Market
                      11.2.3    SWOT Analysis
            11.3    bbi-biotech GmbH
                       11.3.1    Company Overview
                       11.3.2    Role of bbi-biotech GmbH in the Global Next-Generation Biomanufacturing Market
                       11.3.3    SWOT Analysis
            11.4    Danaher Corporation
                       11.4.1    Company Overview
                       11.4.2    Role of Danaher Corporation in the Global Next-Generation Biomanufacturing Market
                       11.4.3    Financials
                       11.4.4    SWOT Analysis
            11.5    Eppendorf AG
                       11.5.1    Company Overview
                       11.5.2    Role of Eppendorf AG in the Global Next-Generation Biomanufacturing Market
                       11.5.3    Financials
                       11.5.4    SWOT Analysis
            11.6    Esco Group of Companies
                       11.6.1    Company Overview
                       11.6.2    Role of Esco Group of Companies in the Global Next-Generation Biomanufacturing Market
                       11.6.3    SWOT Analysis
            11.7    GEA Group Aktiengesellschaft
                       11.7.1    Company Overview
                       11.7.2    Role of GEA Group Aktiengesellschaft in the Global Next-Generation Biomanufacturing Market
                       11.7.3    Financials
                       11.7.4    SWOT Analysis
            11.8    Meissner Filtration Products, Inc.
                       11.8.1    Company Overview
                       11.8.2    Role of Meissner Filtration Products, Inc. in the Global Next-Generation Biomanufacturing Market
                       11.8.3    SWOT Analysis
            11.9    Merck KGaA
                       11.9.1    Company Overview
                       11.9.2    Role of Merck KGaA in the Global Next-Generation Biomanufacturing Market
                       11.9.3    Financials
                       11.9.4    SWOT Analysis
           11.10   PBS Biotech, Inc.
                       11.10.1    Company Overview
                       11.10.2    Role of PBS Biotech, Inc. in the Global Next-Generation Biomanufacturing Market
                       11.10.3    SWOT Analysis
           11.11   Pierre Guérin
                       11.11.1    Company Overview
                       11.11.2    Role of Pierre Guérin in the Global Next-Generation Biomanufacturing Market
                       11.11.3    SWOT Analysis
           11.12   Sartorius AG
                       11.12.1    Company Overview
                       11.12.2    Role of Sartorius AG in the Global Next-Generation Biomanufacturing Market
                       11.12.3    Financials
                       11.12.4    SWOT Analysis
           11.13   Shanghai Bailun Biotechnology Co. Ltd.
                       11.13.1    Company Overview
                       11.13.2    Role of Shanghai Bailun Biotechnology Co. Ltd. in the Global Next-Generation Biomanufacturing Market
                       11.13.3    SWOT Analysis
           11.14   Solaris Biotechnology Srl.
                       11.14.1    Company Overview
                       11.14.2    Role of Solaris Biotechnology Srl. in the Global Next-Generation Biomanufacturing Market
                       11.14.3    SWOT Analysis
           11.15   Thermo Fisher Scientific Inc.
                       11.15.1    Company Overview
                       11.15.2    Role of Thermo Fisher Scientific Inc. in the Global Next-Generation Biomanufacturing Market
                       11.15.3    Financials
                       11.15.4    SWOT Analysis
           11.16   ZETA GmbH
                       11.16.1    Company Overview
                       11.16.2    Role of ZETA GmbH in the Global Next-Generation Biomanufacturing Market
                       11.16.3    SWOT Analysis

List of Tables

Table 1:    Leading Segments of the Global Next-Generation Biomanufacturing Market, 2018 and 2029
Table 4.1:    Impact Analysis of Market Drivers and Restraints
Table 5.1:    Global Regulatory Scenario
Table 5.2:    Patents Granted between January 2018 and December 2019
Table 10.1:    Examples of Biomanufacturers in the U.S. and their Product Offerings

List of Figures

Figure 1:    Global Next-Generation Biomanufacturing Market (by Region), 2018-2029
Figure 2:    Key Players of the Global Next-Generation Biomanufacturing Market
Figure 3:    Drivers and Restraints of the Global Next-Generation Biomanufacturing Market
Figure 4:    Share of Key Developments and Strategies, January 2017-December 2019
Figure 5:    Global Next Generation Biomanufacturing Market (by Workflow), 2018-2029
Figure 6:    Global Next-Generation Biomanufacturing Market Segmentation (by Product)
Figure 7:    Global Next-Generation Biomanufacturing Market for Upstream Processing, 2018-2029
Figure 8:    Global Next-Generation Biomanufacturing Market Share (by Product), 2018-2029
Figure 9:    Global Next Generation Biomanufacturing Market (by Medical Application), 2018-2029
Figure 10:    Global Next Generation Biomanufacturing Market (Commercial Stage, and Preclinical and Development Stage End-User), 2018-2029
Figure 2.1:    Global Next-Generation Biomanufacturing Market Segmentation
Figure 3.1:    Global Next-Generation Biomanufacturing Market Research Methodology
Figure 3.2:    Primary Research
Figure 3.3:    Secondary Research
Figure 3.4:    Data Triangulation
Figure 3.5:    Bottom-up Approach (Segment-wise Analysis)
Figure 3.6:    Top-Down Approach (Segment-wise Analysis)
Figure 3.7:    Assumptions and Limitations
Figure 4.1:    Steps Involved in Bioprocessing
Figure 4.2:    Key Facts Demonstrating Rapid Biopharmaceutical Sector Growth
Figure 4.3:    Global Next-Generation Biomanufacturing Market, 2018-2029
Figure 4.4:    Global Next-Generation Biomanufacturing Market Segmentation
Figure 4.5:    Drivers and Challenges of the Global Next-generation  Biomanufacturing Market
Figure 5.1:    Workflow Associated with Biomanufacturing
Figure 6.1:    Competitive Landscape (January 2017 - December 2019)
Figure 6.2:    Share of Key Developments and Strategies, January 2017-December 2019
Figure 6.3:    Partnerships and Alliances (by Company), January 2017 and December 2019
Figure 6.4:    Business Expansions (by Company), January 2017 and December 2019
Figure 6.5:    New Offerings (by Company), January 2017 and December 2019
Figure 6.6:    M & A Activities (by Company), January 2017 and December 2019
Figure 6.7:    Market Share Analysis of Global Next-Generation Biomanufacturing Market, 2018
Figure 7.1:    Workflow of Upstream and Downstream Biomanufacturing
Figure 7.2:    Global Next Generation Biomanufacturing Market (by Workflow), 2018-2029
Figure 7.3:    Global Next-Generation Biomanufacturing Market Segmentation (by Product)
Figure 7.4:    Global Next Generation Biomanufacturing Market (by Upstream Processing), 2018-2029
Figure 7.5:    Global Next Generation Biomanufacturing Market for Continuous Upstream Biomanufacturing Products, 2018-2029
Figure 7.6:    Global Next Generation Biomanufacturing Market for Bioreactors/Fermentors, 2018-2029
Figure 7.7:    Global Next Generation Biomanufacturing Market for Bags and Containers, 2018-2029
Figure 7.8:    Global Next Generation Biomanufacturing Market for Cell Culture Products, 2018-2029
Figure 7.9:    Global Next Generation Biomanufacturing Market for Filtration Systems, 2018-2029
Figure 7.10:    Global Next Generation Biomanufacturing Market for Mixing Systems, 2018-2029
Figure 7.11:    Global Next Generation Biomanufacturing Market for Sterilizers, 2018-2029
Figure 7.12:    Global Next Generation Biomanufacturing Market for Biosafety Cabinets, 2018-2029
Figure 7.13:    Global Next Generation Biomanufacturing Market for Incubators, 2018-2029
Figure 7.14:    Global Next Generation Biomanufacturing Market for Other Instruments and Accessories, 2018-2029
Figure 7.15:    Global Next Generation Biomanufacturing Market for Single-Use Upstream Biomanufacturing Products, 2018-2029
Figure 7.16:    Global Next Generation Biomanufacturing Market for Single-Use Bioreactors/Fermentors, 2018-2029
Figure 7.17:    Global Next Generation Biomanufacturing Market for Single-Use Bags and Containers, 2018-2029
Figure 7.18:    Global Next Generation Biomanufacturing Market for Single-Use Tubing and Connectors, 2018-2029
Figure 7.19:    Global Next Generation Biomanufacturing Market for Single-Use Mixing Systems, 2018-2029
Figure 7.20:    Global Next Generation Biomanufacturing Market for Single-Use Sensors and Probes, 2018-2029
Figure 7.21:    Global Next Generation Biomanufacturing Market for Downstream Processing, 2018-2029
Figure 7.22:    Global Next Generation Biomanufacturing Market (by Downstream Biomanufacturing Product), 2018-2029
Figure 7.23:    Global Next Generation Biomanufacturing Market for Chromatography Systems, 2018-2029
Figure 7.24:    Global Next Generation Biomanufacturing Market for Filtration Systems, 2018-2029
Figure 7.25:    Global Next Generation Biomanufacturing Market (by Filtration System), 2018-2029
Figure 7.26:    Global Next Generation Biomanufacturing Market for Membrane Adsorbers,  2018-2029
Figure 7.27:    Global Next Generation Biomanufacturing Market for Instruments and Accesories, 2018-2029
Figure 7.28:    Global Next Generation Biomanufacturing Market for Single-Use Equipment and Accessories, 2018-2029
Figure 8.1: Global Next-Generation Biomanufacturing Market Segmentation  (by Medical Application)    
Figure 8.2: Global Next Generation Biomanufacturing Market (by Medical Application),  2018-2029    
Figure 8.3: Global Next Generation Biomanufacturing Market for Monoclonal Antibodies, 2018-2029    
Figure 8.4: Global Next Generation Biomanufacturing Market for Vaccines, 2018-2029    
Figure 8.5: Global Next-Generation Biomanufacturing Market for Recombinant Proteins,  2018-2029    
Figure 8.6: Global Next Generation Biomanufacturing Market for Hormones, 2018-2029    
Figure 8.7: Global Next Generation Biomanufacturing Market for Other Applications, 2018-2029    
Figure 9.1: Global Next-Generation Biomanufacturing Market Segmentation (by End User)    
Figure 9.2: Global Next Generation Biomanufacturing Market (by End User), 2018-2029    
Figure 9.3: Global Next Generation Biomanufacturing Market for Commercial Stage and Preclinical and Development Stage End Users, 2018-2029    
Figure 9.4: Global Next Generation Biomanufacturing Market for Biopharmaceutical Companies, 2018-2029    
Figure 9.5: Global Next-Generation Biomanufacturing Market for CMOs/CDMOs, 2018-2029    
Figure 9.6: Global Next Generation Biomanufacturing Market for Research Institutions, 2018-2029    
Figure 10.1:    Global Next-Generation Biomanufacturing Market (by Region), 2018-2029
Figure 10.2:    North America: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.3:    North America: Market Dynamics
Figure 10.4:    North America: Next-Generation Biomanufacturing Market (by Country),  2018 and 2029
Figure 10.5:    U.S.: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.6:    Canada: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.7:    Europe: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.8:    Europe: Market Dynamics
Figure 10.9:    Europe: Next-Generation Biomanufacturing Market (by Country), 2018 and 2029
Figure 10.10:    Germany: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.11:    France: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.12:    U.K.: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.13:    Italy: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.14:    Spain: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.15:    Ireland: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.16:    Switzerland: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.17:    Russia: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.18:    Rest-of-Europe: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.19:    Asia-Pacific: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.20:    Asia-Pacific: Market Dynamics
Figure 10.21:    Asia-Pacific: Next-Generation Biomanufacturing Market (by Country), 2018-2029
Figure 10.22:    China: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.23:    Japan: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.24:    India: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.25:    South Korea: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.26:    Australia: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.27:    Singapore: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.28:    Rest-of-Asia-Pacific: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.29:    Latin America: Next-Generation Biomanufacturing Market, 2018-2029
Figure 10.30:    Latin America: Next-Generation Biomanufacturing Market (by Country), 2018-2029
Figure 10.31:    Middle East and Africa: Next-Generation Biomanufacturing Market, 2018-2029
Figure 11.1:    Shares of Key Company Profiles
Figure 11.2:    Applikon Biotechnology BV: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.3:    Applikon Biotechnology BV: SWOT Analysis
Figure 11.4:    bbi-biotech GmbH: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.5:    bbi-biotech GmbH: SWOT Analysis
Figure 11.6:    Danaher Corporation: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.7:    Danaher Corporation: Overall Financials, 2016-2018
Figure 11.8:    Danaher Corporation: Revenue (by Business Segment), 2016-2018
Figure 11.9:    Danaher Corporation: Revenue (by Region), 2016-2018
Figure 11.10:    Danaher Corporation: R&D Expenditure (2016-2018)
Figure 11.11:    Danaher Corporation: SWOT Analysis
Figure 11.12:    Eppendorf AG: Product Portfolio for Global Next-Generation  Biomanufacturing Market
Figure 11.13:    Eppendorf AG: Overall Financials, 2016-2018
Figure 11.14:    Eppendorf AG: Revenue (by Region), 2016-2018
Figure 11.15:    Eppendorf AG: R&D Expenditure (2016-2018)
Figure 11.16:    Eppendorf AG: SWOT Analysis
Figure 11.17:    Esco Group of Companies: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.18:    Esco Group of Companies: SWOT Analysis
Figure 11.19:    GEA Group Aktiengesellschaft: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.20:    GEA Group Aktiengesellschaft: Overall Financials, 2016-2018
Figure 11.21:    GEA Group Aktiengesellschaft: Revenue (by Business Segment), 2016-2018
Figure 11.22:    GEA Group Aktiengesellschaft: Revenue (by Region), 2016-2018
Figure 11.23:    GEA Group Aktiengesellschaft: R&D Expenditure (2016-2018)
Figure 11.24:    GEA Group Aktiengesellschaft: SWOT Analysis
Figure 11.25:    Meissner Filtration Products, Inc.: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.26:    Meissner Filtration Products, Inc.: SWOT Analysis
Figure 11.27:    Merck KGaA: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.28:    Merck KGaA: Overall Financials, 2016-2018
Figure 11.29:    Merck KGaA: Revenue (by Segment), 2016-2018
Figure 11.30:    Merck KGaA: Revenue (by Region), 2016-2018
Figure 11.31:    Merck KGaA: R&D Expenditure (2016-2018)
Figure 11.32:    Merck KGaA: SWOT Analysis
Figure 11.33:    PBS Biotech, Inc.: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.34:    PBS Biotech, Inc.: SWOT Analysis
Figure 11.35:    Pierre Guérin: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.36:    Pierre Guérin: SWOT Analysis
Figure 11.37:    Sartorius AG: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.38:    Sartorius AG: Overall Financials, 2016-2018
Figure 11.39:    Sartorius AG: Revenue (by Business Segment), 2016-2018
Figure 11.40:    Sartorius AG: Revenue (by Region), 2016-2018
Figure 11.41:    Sartorius AG: R&D Expenditure (2016-2018)
Figure 11.42:    Sartorius AG: SWOT Analysis
Figure 11.43:    Shanghai Bailun Biotechnology Co. Ltd.: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.44:    Shanghai Bailun Biotechnology Co. Ltd.: SWOT Analysis
Figure 11.45:    Solaris Biotechnology Srl.: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.46:    Solaris Biotechnology Srl.: SWOT Analysis
Figure 11.47:    Thermo Fisher Scientific Inc.: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.48:    Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 11.49:    Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2016-2018
Figure 11.50:    Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 11.51:    Thermo Fisher Scientific Inc.: R&D Expenditure (2016-2018)
Figure 11.52:    Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 11.53:    ZETA GmbH: Product Portfolio for Global Next-Generation Biomanufacturing Market
Figure 11.54:    ZETA GmbH: SWOT Analysis

You may also like

Published Year: 2017

Global Biologics Drug Discovery Market - Analysis and Forecast (2017-2025): (Focus on Method/Phase,

The global biologics drug discovery market was estimated to be $8.9 billion in 2016 and is...

 
Published Year: 2020

Analyst Note:Implications of COVID-19 on Life Sciences Industry

The life sciences industry has been directly impacted by the COVID-19 outbreak. However, the...

Global Next-Generation Biomanufacturing Market – Analysis and Forecast, 2019-2029

Focus on Workflow, Product Type, Medical Applications, End Users, 5 Regional Data, 19 Countries’ Data, and Competitive Landscape